PRIMARY CARE SEQUENTIAL USE OF FIB-4 AND THE ENHANCED LIVER FIBROSIS TEST TO STRATIFY PATIENTS WITH NONALCOHOLIC FATTY LIVER ACIDE DOUBLES CIRRHOSIS DETECTION AND REDUCES REFERRALS OF PATIENTS WITH MILD DISEASE

被引：0
|
作者：
Srivastava, A. [1 ,2 ]
Gailer, R. [3 ]
Demma, S. [1 ,2 ]
Warner, A. [3 ]
Suri, D. [4 ]
Morgan, S.
Tanwar, S. [1 ]
Sennett, K. [5 ]
Thorburn, D. [1 ,2 ]
Parkes, J. [1 ,6 ]
Tsochatzis, E. [1 ,2 ]
Rosenberg, W. [1 ,2 ]
机构：
[1] UCL, Inst Liver & Digest Hlth, London, England
[2] Royal Free London NHS Fdn Trust, Hepatol & Liver Transplantat, London, England
[3] UCL, Primary Care & Populat Hlth, London, England
[4] Whittington Hosp, Dept Hepatol, London, England
[5] Islington Clin Commissioning Grp, Primary Care, London, England
[6] Univ Southampton, Publ Hlth Sci & Med Stat, Southampton, Hants, England
来源：
JOURNAL OF HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
10.1016/S0168-8278(16)00802-3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-280
引用
收藏
页码：S474 / S475
页数：2
相关论文
共 50 条
  • [21] Gaps in Confirmatory Fibrosis Risk Assessment in Primary Care Patients with Nonalcoholic Fatty Liver Disease
    Joseph A. Moore
    William H. Wheless
    Jingwen Zhang
    Justin Marsden
    Patrick D. Mauldin
    William P. Moran
    Andrew D. Schreiner
    Digestive Diseases and Sciences, 2023, 68 : 2946 - 2953
  • [22] Gaps in Confirmatory Fibrosis Risk Assessment in Primary Care Patients With Nonalcoholic Fatty Liver Disease
    Moore, Joseph A.
    Zhang, Jingwen
    Schreiner, Andrew D.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S964 - S965
  • [23] Using the FIB-4, automatically calculated, followed by the ELF test in second line to screen primary care patients for liver disease
    Ouzan, Denis
    Penaranda, G.
    Jlaiel, M.
    Joly, H.
    Corneille, J.
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [24] Diagnostic Accuracy of FIB-4 and FIB-5 Scores as Compared to Fibroscan for Assessment of Liver Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease
    Kumari, Bandana
    Kumar, Ramesh
    Sharma, Sadhana
    Banerjee, Ayan
    Kumar, Visesh
    Kumar, Pawan
    Chaudhary, Neha
    Kumar, Sushil
    Raj, Khushboo
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (08)
  • [25] Assessment of hepatic fibrosis screening in primary care using the FIB-4 score, followed in second line by an ELF (Enhanced liver Fibrosis) test
    Ouzan, Denis
    Penaranda, Guillaume
    Malik, Jlaiel
    Jeremie, Corneille
    JOURNAL OF HEPATOLOGY, 2023, 78 : S684 - S685
  • [26] Underrecognition and Suboptimal Quality of Care for Nonalcoholic Fatty Liver Disease Cirrhosis in Primary Care Patients with Diabetes Mellitus
    Chu, Janet N.
    Goldman, Max L.
    Brandman, Danielle
    Sohn, Jae Ho
    Islam, Kendall
    Ross, Lauren A.
    Fox, Rena K.
    AMERICAN JOURNAL OF MEDICINE, 2024, 137 (02): : 172 - 177.e2
  • [27] MEASURES OF CARDIOMETABOLIC RISK AND ADVANCED FIBROSIS IN PRIMARY CARE PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Schreiner, Andrew
    HEPATOLOGY, 2023, 78 : S1004 - S1004
  • [28] The Fatty Liver Index (FLI) is more accurate than FIB-4 for detection of advanced liver fibrosis in patients with type-2 Diabetes Mellitus (T2DM) in Primary Care
    Nadal, Ruth
    Juanola, Adria
    Hoyo, Jordi
    Martinez, Sara
    Carvelli, Ana
    Soria, Anna
    Sanz-Rodriguez, Maria
    Carol, Marta
    Perez-Guasch, Martina
    Cervera, Marta
    Garcia, Ana Belen Rubio
    Pellon, Miriam
    Alvarez, Marife
    Lopez, Marina Gigante
    Herreros, Yolanda
    Pozo, Cristina
    Riba, Carlota
    Moreta, Maria Jose
    Gratacos-Gines, Jordi
    Pose, Elisa
    Graupera, Isabel
    Gines, Pere
    Fabrellas, Nuria
    JOURNAL OF HEPATOLOGY, 2024, 80 : S541 - S542
  • [29] The FIB-4 Index Is a Useful Predictor for the Development of Hepatocellular Carcinoma in Patients with Coexisting Nonalcoholic Fatty Liver Disease and Chronic Hepatitis B
    Kim, Minah
    Lee, Yeonju
    Yoon, Jun Sik
    Lee, Minjong
    Kye, So Shin
    Kim, Sun Woong
    Cho, Yuri
    CANCERS, 2021, 13 (10)
  • [30] FIB-4 AND FIBROSCAN CAN IDENTIFY PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE WHO ARE AT RISK OF LIVER-RELATED EVENTS: RESULTS OF A LONGITUDINAL ANALYSIS WITH COMPARISON WITH LIVER BIOPSY
    Boursier, Jerome
    Hagstrom, Hannes
    Ekstedt, Mattias
    Moreau, Clemence
    Bonacci, Martin
    Cures, Sandrine
    Trylesinski, Aldo
    Romero-Gomez, Manuel
    HEPATOLOGY, 2020, 72 : 967 - 967
12345